Nanomaterials provide a possible path forward at a time of rising antibiotic resistance and an urgent need for new therapeutic techniques. This chapter summarizes a thorough investigation of the production, properties, processes, and use of nanomaterials for the treatment of bacterial diseases. These nanomaterials often exhibit nanoscale characteristics that have improved interactions with bacterial pathogens compared to their bulk counterparts. The need to design nanomaterials with specific characteristics to achieve the best antibacterial activity is emphasized. Nanomaterials have the ability to undermine bacterial defense systems and limit the spread of infections by specifically targeting bacterial cell walls, membranes, and even intracellular components. This chapter has also discussed the difficulties and opportunities of clinical translation, imagining nanomaterials as adjuvants or solo therapies in the treatment of bacterial infections. The effects of regulatory issues, possible toxicity, and tailored delivery methods on clinical effectiveness and safety are comprehensively reviewed. In summary, this chapter captures a crucial turning point when nanotechnology and microbiology intersect to address one of the most urgent issues in world health. This comprehensive package also offers a road map for novel strategies to fight bacterial infections and lessen the effects of antibiotic resistance by analyzing the complex molecular mechanisms and highlighting the versatile roles of nanomaterials in bacterial infection intervention.